Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3

Fig. 3

Gene expression of extracellular matrix components and activator-protein 1 components. The mRNA expression of type I (Col1a1) and type III (Col3a1) collagens were significantly elevated in TGF-β1 kidneys (a, b), accompanied by marked TIMP-1 mRNA (Timp1) overexpression (c) with reduced MMP-9/TIMP-1 ratio (d) which were attenuated by pioglitazone. Kidneys of untreated TGF-β1 mice also had elevated cFos and cJun expression, normalized by pioglitazone treatment (e, f). Kruskal-Wallis test (n = 7/group), *:p < 0.05, **:p < 0.01

Back to article page